Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
---|
12/25/2008 | US20080319072 Composition and method for treating bacterial, viral, fungal diseases, inflammation and pain |
12/25/2008 | US20080319067 Acetic acid, 6-(4-chlorophenyl-8,9-dimethoxy-1,2,3,4,4a,10b-hexahydrophenanthridin-2-yl) ester; nontoxic; high bioavailability; side effect reduction; pharmakinetics;antiallergens; antiinflammatory agents; skin disorders; bronchodilators; asthma; psoriasis; eczema; antiarthritic agents |
12/25/2008 | US20080319044 Compounds and Methods of Use Thereof |
12/25/2008 | US20080318980 USE OF 7-(PYRIMIDIN-4 YL)-IMIDAZO[1,2-a]PYRIMIDIN-5(1H)-ONES AS GSK-3BETA INHIBITORS |
12/25/2008 | US20080318967 Hair Growth Promoting Agents |
12/25/2008 | US20080318960 PAR2-modulating compounds and their use |
12/25/2008 | US20080318942 Fredericamycin Derivatives |
12/25/2008 | US20080318915 Deuterium-enriched fluticasone propionate |
12/25/2008 | US20080318910 Controlled-Release Oral Dosage Form |
12/25/2008 | US20080318901 enhancing wound repair; treating reperfusion type injury; lyso-lipid phosphate phosphatase inhibitor; phosphoric acid mono-[3-(4-phenyloxy-pyrimidine)-2-octadec-9-enoylamino-propyl] ester or salt |
12/25/2008 | US20080318869 Method to Promote Wound Healing |
12/25/2008 | US20080318860 High Activity Growth Factor Mutants |
12/25/2008 | US20080318293 Sulfotransferase Inhibitors |
12/25/2008 | US20080317889 dissolving emulsion/emollient in alcohol; clarity; free of acetone and other harsh, dermatologically undesirable solvents; acne vulgaris, rosacea |
12/25/2008 | US20080317836 Topical compositions for anti-aging skin treatment |
12/25/2008 | US20080317749 Use of Cytokine Expression to Predict Skin Inflammation; Methods of Treatment |
12/25/2008 | US20080317748 Using DCRS5 cytokine receptors modulators to treat psoriasis and atopic dermatitis |
12/25/2008 | US20080317737 Drug combination for the treatment of skin disorders |
12/25/2008 | US20080317733 Cosmeceutical Compositions and Methods with Biologically Active Ingredients |
12/25/2008 | US20080317730 Compositions Useful for Recovering Original Trophism and Pigmentation, and for Stimulating Growth of the Integumentary Apparatus, Uses and Products Thereof |
12/25/2008 | US20080317723 Lymphatic endothelial cells materials and methods |
12/25/2008 | US20080317705 Promoting Wound Healing by Administering a Prostaglandin E and Granulocyte-Macrophage Colony Stimulating Factor |
12/25/2008 | US20080317695 Hair Care Compositions |
12/25/2008 | US20080317684 Topical Compositions |
12/25/2008 | US20080317679 Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
12/24/2008 | WO2008157786A1 Substituted n-aryl pyridinones as fibrotic inhibitors |
12/24/2008 | WO2008157627A1 Use of propofol prodrugs for treating alcohol withdrawal, central pain, anxiety or pruritus |
12/24/2008 | WO2008156685A2 Tendon stem cells |
12/24/2008 | WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | WO2008156094A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | WO2008155659A2 Compositions for preventing or treating skin defects and methods of use thereof |
12/24/2008 | WO2008155535A1 Use of halogenated salicylanilides for the treatment of acne |
12/24/2008 | WO2008155520A2 4-hydroxy benzoate derivatives for use in the treatment of infection, inflammation or pain |
12/24/2008 | WO2008154898A2 Preparation for the treatment of equine laminitis |
12/24/2008 | WO2008154867A1 Material with immunogenicity |
12/24/2008 | WO2008051291A3 Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof |
12/24/2008 | EP2005959A1 External pharmaceutical composition |
12/24/2008 | EP2005958A1 External pharmaceutical composition |
12/24/2008 | EP2004656A1 Thienopyrimidines having mnkl /mnk2 inhibiting activity for pharmaceutical compositions |
12/24/2008 | EP2004597A2 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain |
12/24/2008 | EP2004576A1 New method for the manufacture of therapeutic compounds and compositions, compounds and compositions produced therewhith, and their use |
12/24/2008 | EP2004198A2 Method of treating pediatric patients with corticosteroids |
12/24/2008 | EP2004169A1 Oral composition comprising a polyunsaturated fatty acid and salicylic acid for obtaining an antiinflammatory effect in skin |
12/24/2008 | EP2004162A1 Use of polyamines in the treatment of psoriasis |
12/24/2008 | EP2004161A1 Oral composition comprising dha and genistein for enhancing skin properties |
12/24/2008 | EP2004160A1 Oral composition with an antiageing effect on the skin |
12/24/2008 | EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors |
12/24/2008 | EP1441746B1 Composition and method |
12/24/2008 | EP1401418B1 Topical treatments using alkanolamines |
12/24/2008 | EP1373206B1 Aryl oxime-piperazines useful as ccr5 antagonists |
12/24/2008 | DE202008013612U1 Medizinisches Präparat auf pflanzlicher Basis Medical preparation plant-based |
12/24/2008 | DE102008017031A1 Kohlenwasserstoff Gemische und ihre Verwendung Hydrocarbon mixtures and their use |
12/24/2008 | CN201167623Y Insoles for treating beriberi |
12/24/2008 | CN101331134A Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof |
12/24/2008 | CN101330935A Isolation and cultivation of stem/progenitor cells from the amniotic membrane of umbilical cord and uses of cells differentiated therefrom |
12/24/2008 | CN101328472A Epidermal growth factor culture fluid, externally used drug for curing diabetes trauma using the culture fluid and preparation of the externally used drug |
12/24/2008 | CN101328228A Tang oligosaccharide, preparation thereof and use in radioresistant medicaments |
12/24/2008 | CN101328159A Taxone precursor anti-cancer drugs, medicinal composition and use thereof |
12/24/2008 | CN101328135A Carbonyl phenyl propanoic acid derivative compounds |
12/24/2008 | CN101327318A Mesenchyma stem cell suspension containing cell growth factor and uses thereof |
12/24/2008 | CN101327298A Chinese medicine for treating pruritus dermatopathy |
12/24/2008 | CN101327286A Pain-relieving anti-inflammation medicament and preparation method thereof and use |
12/24/2008 | CN101327279A Medicament for treating skin disease and preparation thereof |
12/24/2008 | CN101327273A Medicament for treating psoriasis and preparation thereof |
12/24/2008 | CN101327268A Oral chinese medicine for treating solar urticaria |
12/24/2008 | CN101327264A Medicament for treating leukoderma and preparation method thereof |
12/24/2008 | CN101327231A Chinese medicinal composition for treating psoriasis |
12/24/2008 | CN101327189A Method for preparing nano alcohol liposome material with mark and treatment double-function |
12/24/2008 | CN101327179A Medicinal cosmetics for treating acne and scar thereof with antianaphylaxis function |
12/24/2008 | CN101327168A Method for extracting sea mud active component |
12/24/2008 | CN101327002A Health care food for beauty treatment and face nursing |
12/24/2008 | CN101326945A Jujube chestnut leaf tea |
12/24/2008 | CN100444894C Methods and compositions for the promotion of hair growth utilizing actin binding peptides |
12/24/2008 | CN100444893C Medicine for treating alopecia areata and its preparing method |
12/24/2008 | CN100444885C Powder containing fingered citron and citron |
12/24/2008 | CN100444850C Chinese traditional medicine for treating skin diseases |
12/24/2008 | CN100444841C Externally used loratadine formulation |
12/24/2008 | CN100444839C Treatment of chemokine mediated diseases |
12/24/2008 | CN100444824C Aloe melt glue and active synergistic alimentary cosmetic liquid |
12/24/2008 | CA2692249A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | CA2692248A1 Pyridazinone derivative and pde inhibitor containing the same as active ingredient |
12/24/2008 | CA2691379A1 Substituted n-aryl pyridinones |
12/24/2008 | CA2691091A1 Fusion protein, macromolecule assembled from the fusion protein, and its use in the prevention or treatment of human papillomavirus related diseases |
12/23/2008 | US7468421 Administering andothelins, or antagonist thereof, as drug or cosmetics for hair removal or wool harvesting |
12/23/2008 | US7468380 Nitrogen-containing aromatic derivatives |
12/23/2008 | US7468368 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
12/23/2008 | US7468361 For therapy of skin conditions selected from the group consisting of dermatitis, eczema, keratosis, lack of skin firmness, wrinkles, lack of dermal hydration and insufficient sebum secretion |
12/23/2008 | US7468359 Compositions comprising oxophosphonate-based metalloproteinase inhibitors |
12/23/2008 | US7468356 Modulation of insulin like growth factor I receptor expression |
12/23/2008 | US7468276 Bloodless mammalian placenta for use in generating multipotent stem cells |
12/23/2008 | US7468270 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
12/23/2008 | CA2360676C A method for treating patients with acne by administering a cyclic gmp pde inhibitor |
12/23/2008 | CA2307040C Multilayer conductive appliance having wound healing and analgesic properties |
12/23/2008 | CA2246397C Solid and semi-solid hydrocarbon gels and uses thereof |
12/23/2008 | CA2245267C Crystal form of n-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
12/23/2008 | CA2178594C Absorption enhancers for topical pharmaceutical formulations |
12/18/2008 | WO2008154389A1 Aldosterone induced elastin production |
12/18/2008 | WO2008153662A2 Skin firming and lifting compositions and methods of use |
12/18/2008 | WO2008153385A1 Urocanic acid derivatives useful for the treatment of immune-related and inflammatory diseases |
12/18/2008 | WO2008153027A1 Pyrroloquinoline derivative and use thereof |